SCHEMBL2531386

SCHEMBL2531386

CCOC(=O)c1ccc2c(c1)CC(C)(C)C(c1cc(F)cc(N3CCCC3)c1)N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 3/20 0.40
SIRT1 Q96EB6 2/20 0.40
ALDH1A1 P00352 3/20 0.37
MAPK1 P28482 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 3/20 0.36
AR P10275 1/20 0.36
MEN1 O00255 2/20 0.35
POLB P06746 2/20 0.35
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MASP2 O00187 1/20 0.35
GAPDH P04406 1/20 0.35
HSPA1A P0DMV8 1/20 0.35
THRB P10828 1/20 0.35
HSPA8 P11142 1/20 0.35
HPGD P15428 1/20 0.35
ALOX15 P16050 1/20 0.35
NR4A1 P22736 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2535035 0.93 BCL9 (0.37) SIRT2SIRT1ALDH1A1MAPK1GAA
SCHEMBL2530573 0.91 GAA (0.36) ALDH1A1GAAMAPTARMEN1
SCHEMBL2535709 0.89 AR (0.41) ALDH1A1MAPK1MAPTARMEN1
SCHEMBL2531318 0.88 HSD17B10 (0.41) ALDH1A1MAPK1GAAMAPTKDM4E
SCHEMBL2532994 0.87 TTR (0.37) ALDH1A1MAPK1GAAMAPTMEN1
SCHEMBL2532955 0.86 ALDH1A1 (0.40) ALDH1A1MAPK1GAAMAPTAR
SCHEMBL14331349 0.86 HTR1D (0.35) SIRT2ALDH1A1MAPK1GAAMAPT
SCHEMBL2538194 0.84 AR (0.38) SIRT2ALDH1A1MAPK1MAPTAR
SCHEMBL2535104 0.83 SIRT2 (0.44) SIRT2SIRT1ALDH1A1MAPK1GAA
SCHEMBL2530590 0.83 HSD17B10 (0.38) SIRT2SIRT1ALDH1A1MAPK1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 SIRT2 284/4885SIRT1 249/4885ALDH1A1 552/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 SIRT2 284/4885SIRT1 249/4885ALDH1A1 552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.